189
Views
0
CrossRef citations to date
0
Altmetric
Myopia

Novel Findings about Myopia in Patients with Oculodermal Melanocytosis (Nevus of Ota)

, , , , &
Pages 1047-1050 | Received 13 Mar 2020, Accepted 19 Nov 2020, Published online: 05 Feb 2021
 

ABSTRACT

Purpose: To test the hypothesis that ocular pigment in patients with oculodermal melanocytosis decreases myopia severity.

Methods: Refractive and biometric parameters were measured and compared between pigmented eyes and non-pigmented contralateral eyes in oculodermal melanocytosis patients that underwent surgical ocular pigmentation removal. To assess pigmentation, the pigmentation score was measured in each quadrant of the sclera and added together for a cumulative score. For subgroup analyses, patients were categorized into three groups according to the severity of myopia in the non-pigmented eye.

Results: Fifty-five patients (110 eyes) were included. Spherical power and spherical equivalent were significantly less myopic in pigmented eyes relative to contralateral non-pigmented eyes. The spherical powers of non-pigmented eyes were positively correlated with the difference in spherical power between contralateral eyes (r = 0.697, p < .001). The pigmentation scores of pigmented eyes were positively correlated with the ratio of myopia inhibition (r = 0.373, p = .005). In subgroup analyses, pigmented eyes exhibited significantly less myopic spherical powers and spherical equivalents than non-pigmented contralateral eyes in the moderate and high myopia groups. Pigmented eyes exhibited significantly shorter axial length than non-pigmented contralateral eyes in the high myopia group only.

Conclusions: In patients with oculodermal melanocytosis, pigmented eyes exhibited less severe myopia relative to non-pigmented contralateral eyes. This suggested that ocular pigmentation inhibited myopic changes, potentially by blocking UV transmission. This study will be helpful in elucidating the mechanisms of myopic progression.

Declaration of interest

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.